SILVESTRIS, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 22.765
AS - Asia 7.942
EU - Europa 6.973
SA - Sud America 1.980
Continente sconosciuto - Info sul continente non disponibili 722
AF - Africa 333
OC - Oceania 17
Totale 40.732
Nazione #
US - Stati Uniti d'America 22.435
SG - Singapore 3.276
IT - Italia 2.014
CN - Cina 1.985
BR - Brasile 1.550
SE - Svezia 1.101
HK - Hong Kong 901
RU - Federazione Russa 744
DE - Germania 665
UA - Ucraina 586
VN - Vietnam 518
FI - Finlandia 501
FR - Francia 466
GB - Regno Unito 429
IN - India 247
BD - Bangladesh 208
CA - Canada 183
AR - Argentina 142
ID - Indonesia 111
IQ - Iraq 99
PL - Polonia 89
ZA - Sudafrica 89
TR - Turchia 88
CI - Costa d'Avorio 81
CO - Colombia 69
BE - Belgio 68
MX - Messico 67
PK - Pakistan 62
EC - Ecuador 61
SA - Arabia Saudita 61
IE - Irlanda 55
NL - Olanda 53
VE - Venezuela 53
UZ - Uzbekistan 43
JP - Giappone 42
MY - Malesia 41
PH - Filippine 41
CL - Cile 37
ES - Italia 34
MA - Marocco 34
AT - Austria 33
LT - Lituania 31
KE - Kenya 28
TN - Tunisia 27
NP - Nepal 25
JO - Giordania 22
PY - Paraguay 21
AE - Emirati Arabi Uniti 19
BO - Bolivia 17
IR - Iran 17
EG - Egitto 16
JM - Giamaica 15
AU - Australia 14
CZ - Repubblica Ceca 14
ET - Etiopia 14
OM - Oman 14
PE - Perù 14
PS - Palestinian Territory 14
UY - Uruguay 13
AL - Albania 12
AZ - Azerbaigian 12
CR - Costa Rica 12
IL - Israele 11
KR - Corea 10
RS - Serbia 10
KZ - Kazakistan 9
TH - Thailandia 9
DK - Danimarca 8
GR - Grecia 8
LB - Libano 8
QA - Qatar 8
CH - Svizzera 7
DO - Repubblica Dominicana 7
HN - Honduras 7
LV - Lettonia 7
SN - Senegal 7
TT - Trinidad e Tobago 7
GT - Guatemala 6
KG - Kirghizistan 6
KW - Kuwait 6
XK - ???statistics.table.value.countryCode.XK??? 6
DZ - Algeria 5
EU - Europa 5
GE - Georgia 5
HR - Croazia 5
HU - Ungheria 5
NG - Nigeria 5
RO - Romania 5
SY - Repubblica araba siriana 5
AM - Armenia 4
BB - Barbados 4
EE - Estonia 4
LY - Libia 4
MU - Mauritius 4
PT - Portogallo 4
AO - Angola 3
BH - Bahrain 3
BZ - Belize 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
Totale 39.959
Città #
Fairfield 2.190
Ashburn 1.926
Singapore 1.761
Woodbridge 1.617
Chandler 1.482
Jacksonville 1.347
San Jose 1.200
Houston 1.118
Dallas 1.065
Hong Kong 895
Seattle 869
Milan 846
Nyköping 817
Cambridge 801
Wilmington 710
Ann Arbor 656
Beijing 626
Council Bluffs 386
Nanjing 355
Lawrence 349
Roxbury 342
Lauterbourg 305
New York 267
Rome 234
Des Moines 229
Los Angeles 226
Helsinki 204
Boardman 163
Brooklyn 158
Santa Clara 150
Ho Chi Minh City 146
São Paulo 145
Princeton 133
Columbus 127
Bari 123
Inglewood 123
Munich 107
Hanoi 99
San Diego 91
Figino 86
Buffalo 85
Nanchang 83
Shenyang 82
Abidjan 81
London 81
Dong Ket 77
Dearborn 74
Hebei 72
Chicago 68
Warsaw 67
Brussels 65
Jiaxing 59
North Bergen 59
Turin 56
Dublin 55
Montreal 54
Toronto 54
Tianjin 52
Frankfurt am Main 50
Jakarta 49
Rio de Janeiro 47
Denver 45
Nuremberg 43
Redwood City 43
Paris 41
Phoenix 41
Guangzhou 40
Tokyo 40
Johannesburg 39
Tashkent 37
Changsha 36
Atlanta 35
Moscow 35
Belo Horizonte 34
San Francisco 33
Baghdad 32
Chennai 32
Orem 31
Bologna 28
Dhaka 27
Pune 27
Stockholm 27
Washington 27
Amsterdam 26
Marseille 26
Brasília 25
Curitiba 25
Porto Alegre 25
Guayaquil 24
Naples 24
Riyadh 24
Ankara 23
Poplar 23
The Dalles 23
Charlotte 22
Kuala Lumpur 22
New Delhi 22
San Mateo 22
Nairobi 21
Salvador 21
Totale 27.015
Nome #
1,25(OH)2 vitamin D(3) contributes to osteoclast-like trans-differentiation of malignant plasma cells 1.074
Ruolo degli agonisti dei recettori sigma-2 nei fenomeni di farmacoresistenza associati alla chemioterapia nel mieloma multiplo 948
25 Hydroxyvitamin D Levels Are Negatively And Independently Associated With Fat Mass In A Cohort Of Healthy Overweight And Obese Subjects 224
Animal-type melanoma: Dog or wolf? A review of the literature and a case report 217
Obesity and Breast Cancer: Molecular Interconnections and Potential Clinical Applications 198
Adenocarcinoma of the ceruminous glands: role of the VMAT 198
The metabolic milieu in melanoma: Role of immune suppression by CD73/adenosine 198
Cilengitide restrains the osteoclast-like bone resorbing activity of myeloma plasma cells. 197
Pros-IT CNR: an Italian prostate cancer monitoring project 193
Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology 192
PIL6-TRAIL-engineered umbilical cord mesenchymal/stromal stem cells are highly cytotoxic for myeloma cells both in vitro and in vivo 188
Tumor-derived exosomes promote the in vitro osteotropism of melanoma cells by activating the SDF-1/CXCR4/CXCR7 axis. 187
Cutaneous metastasis as a primary presentation of a pulmonary enteric adenocarcinoma 186
Platelet number is positively and independently associated with glycated hemoglobin in non-diabetic overweight and obese subjects 185
Relationship between C3 Levels and Common Carotid Intima-Media Thickness in Overweight and Obese Patients 184
Defective levels of both circulating dendritic cells and T-regulatory cells correlate with risk of recurrence in cutaneous melanoma 184
Characterization of a rare nonpathogenic sequence variant (c.1905C>T) of the dihydropyrimidine dehydrogenase gene (DPYD) 183
Immune system and melanoma biology: A balance between immunosurveillance and immune escape 183
Exosomes in melanoma: A role in tumor progression, metastasis and impaired immune system activity 183
Reviewing the Osteotropism in Neuroendocrine Tumors: The Role of Epithelial-Mesenchymal Transition 183
Everolimus restrains the paracrine pro-osteoclast activity of breast cancer cells 183
The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma. 181
Next-generation Sequencing (NGS) Analysis on Single Circulating Tumor Cells (CTCs) with No Need of Whole-genome Amplification (WGA) 180
Bendamustine overcomes resistance to melphalan in myeloma cell lines by inducing cell death through mitotic catastrophe 177
Osteotropism of neuroendocrine tumors: Role of the CXCL12/ CXCR4 pathway in promoting EMT in vitro 175
Para- and perirenal ultrasonographic fat thickness is associated with 24-hours mean diastolic blood pressure levels in overweight and obese subjects 175
Dissection of major cancer gene variants in subsets of circulating tumor cells in advanced breast cancer. 174
Erdheim-Chester disease: A systematic review. 172
Extracellular Vesicles and Epigenetic Modifications Are Hallmarks of Melanoma Progression 172
Platelet number is negatively and independently associated with carotid intima-media thickness in apparently healthy overweight/obese subjects 171
Avβ3 integrin: Pathogenetic role in osteotropic tumors 170
Dual-procedural separation of CTCs in cutaneous melanoma provides useful information for both molecular diagnosis and prognosis 170
Double heterozygosity for BRCA1 pathogenic variant and BRCA2 polymorphic stop codon K3326X: A case report in a southern Italian family 168
Cancer treatment-induced bone loss (CTIBL): Pathogenesis and clinical implications. 168
The Tumor Microenvironment in Neuroendocrine Tumors: Biology and Therapeutic Implications 168
Immune System Evasion as Hallmark of Melanoma Progression: The Role of Dendritic Cells. 167
Characterization of a Rare Nonpathogenic Methylenetetrahydrofolatereductase (MTHFR) Gene Mutation p.Lys215del in a Southern Italian family 163
Sirtuins and Cancer: Role in the Epithelial-Mesenchymal Transition 162
New insights into the molecular pathogenesis of langerhans cell histiocytosis 161
Everolimus restrains the IL-17A-dependent osteoclast-like transdifferentiation of dendritic cells in multiple myeloma 159
Independent relationship of osteocalcin circulating levels with obesity, type 2 diabetes, hypertension, and HDL cholesterol 159
[Genomics of lung adenocarcinoma: pathogenetic significance and clinical applications.] 159
The Role of Cytotoxic Chemotherapy in Well-Differentiated Gastroenteropancreatic and Lung Neuroendocrine Tumors. 159
[Apoptosis or programmed cell death: regulatory and pathophysiological mechanisms]. FT Apoptosi, o morte cellulare programmata: meccanismi regolatori e fisiopatologia. 158
PTHrP produced by myeloma plasma cells regulates their survival and pro-osteoclast activity for bone disease progression. 158
Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations 157
Abdominal obesity is characterized by higher pulse pressure: possible role of free triiodothyronine 156
Anti-Fas (CD95/Apo-I) autoantibodies and soluble Fas levels concur in T cell depletion in HIV type 1 infection 156
Higher Waist Circumference, Fasting Hyperinsulinemia And Insulin Resistance Characterize Hypertensive Patients With Impaired Glucose Metabolism 156
CORRIGENDUM to The mechanisms of acute interstitial nephritis in the era of immune checkpoint inhibitors in melanoma 155
ALK gene alterations in cancer: Biological aspects and therapeutic implications 153
DEAD-Box Helicase 4 (Ddx4)+ Stem Cells Sustain Tumor Progression in Non-Serous Ovarian Cancers 153
Up-regulation of IL-18 and predominance of a Th1 immune response is a hallmark of lupus nephritis 152
An imbalance between Beclin-1 and p62 expression promotes the proliferation of myeloma cells through autophagy regulation. 152
NETs: Organ-related epigenetic derangements and potential clinical applications 152
Cytotherapies in multiple myeloma: a complementary approach to current treatments 151
Anemia in multiple myeloma: role of deregulated plasma cell apoptosis 150
Bone Metastases from Solid Tumors: In Search of Predictive Biomarkers for Clinical Translation 149
null 149
In vitro differentiation of human oocyte-like cells from oogonial stem cells: single-cell isolation and molecular characterization 148
Immune Profile of Obese People and In Vitro Effects of Red Grape Polyphenols on Peripheral Blood Mononuclear Cells. 148
Rare dihydropyrimidine dehydrogenase variants and toxicity by floropyrimidines: A case report 147
CD8+/CD57 cells and apoptosis suppress T-cell functions in multiple myeloma 146
Does cilengitide deserve another chance? 146
The Italian quality control study for evaluation of CD4 cells in centres involved in the treatment of HIV-1 patients 146
Revisiting the Role of Exosomes in Colorectal Cancer: Where Are We Now? 145
Independent relationship between serum osteocalcin and uric acid in a cohort of apparently healthy obese subjects 144
Serum exosomes as predictors of clinical response to ipilimumab in metastatic melanoma 144
Vitamin D in melanoma: Controversies and potential role in combination with immune check-point inhibitors 144
IgG M-components in active myeloma patients induce a down-regulation of natural killer cell activity 143
Lenalidomide exerts cytostatic activity on melanoma cells by negative regulation of their cell cycle 143
Cell fusion and hyperactive osteoclastogenesis in multiple myeloma 141
Molecular Assessment of Ovarian Cancer and Translation to Clinical Management 141
Uric acid, metabolic syndrome and atherosclerosis: the chicken or the egg, which comes first? 140
A peculiar molecular profile of umbilical cord-mesenchymal stromal cells drives their inhibitory effects on multiple myeloma cell growth and tumor progression. 139
Autocrine production of interleukin-6 (IL-6) by highly malignant myeloma cells 138
Immune-related adverse events during anticancer immunotherapy: Pathogenesis and management 138
Pulmonary enteric adenocarcinoma: An overview 138
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 138
AlphaVBeta3+ (AvB3) adhesion molecule drives the osteoclast (OC)-like functional differentiation of myeloma cells (MC) 137
Recent advances in understanding the pathogenesis of anemia in multiple myeloma 137
Cytokine Overproduction, T-Cell Activation, and Defective T-Regulatory Functions Promote Nephritis in Systemic Lupus Erythematosus 137
Urokinase Receptor (uPAR) Ligand based Recombinant Toxins for Human Cancer Therapy 137
Amyloidosis: clinical picture, immunological and biomolecular features, treatment prospects 136
Mediterranean Diet and cancer risk: an open issue 136
An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival 135
[Methods for assessing programmed cell death]. FT Metodiche di valutazione della morte cellulare programmata. 134
Fas/Fas-ligand (Fas-L)-deregulated apoptosis and IL-6 insensitivity in highly malignant myeloma cells 134
Impaired osteoblastogenesis in myeloma bone disease: role of upregulated apoptosis by cytokines and malignant plasma cells 133
Desmoid tumors in familial adenomatous polyposis 133
Immature dendritic cells from patients with multiple myeloma are prone to osteoclast differentiation in vitro 132
Low 25 Hydroxyvitamin D Levels are Independently Associated with Autoimmune Thyroiditis in a Cohort of Apparently Healthy Overweight and Obese Subjects 132
Upregulation of osteoblast apoptosis by malignant plasma cells: a role in myeloma bone disease 130
The management of refractory carcinoid syndrome: challenges and opportunities ahead 129
SNPs in predicting clinical efficacy and toxicity of chemotherapy: Walking through the quicksand 129
Large extracellular vesicles—a new frontier of liquid biopsy in oncology 128
In-vitro functional phenotypes of plasma cell lines from patients with multiple myeloma 127
[Malignant neoplasms and AIDS. Review of the literature and critical considerations on a case of epidermoid carcinoma of the anus]. FT Neoplasie maligne e AIDS. Rassegna della letteratura e considerazioni critiche su un caso di carcinoma epidermoide dell'ano. 127
Possible role of hyperinsulinemia and insulin resistance in lower vitamin D levels in overweight and obese patients. 127
Amyloidosis: clinical picture, immunological and biomolecular features, treatment prospects. 126
Totale 17.468
Categoria #
all - tutte 170.671
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 170.671


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.056 0 0 28 123 117 175 101 140 139 171 419 643
2022/20233.947 610 420 222 345 473 541 41 438 711 26 71 49
2023/20241.312 116 273 75 191 108 240 36 67 8 38 19 141
2024/20255.307 138 62 559 233 132 436 364 482 254 289 730 1.628
2025/202613.208 1.726 637 1.306 1.248 1.175 625 1.359 314 1.032 1.145 1.218 1.423
2026/20271.273 284 508 481 0 0 0 0 0 0 0 0 0
Totale 40.732